HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anand Kumar Pandey Selected Research

Tissue Plasminogen Activator (Alteplase)

9/2012Neuroprotective potential of Piroxicam in cerebral ischemia: an in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and acid sensing ion channel1a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anand Kumar Pandey Research Topics

Disease

12Brain Ischemia (Cerebral Ischemia)
08/2022 - 01/2011
5Stroke (Strokes)
12/2014 - 07/2012
4Ischemic Stroke
08/2016 - 04/2014
4Ischemia
08/2016 - 01/2012
4Cerebral Infarction
01/2015 - 01/2013
4Brain Edema (Cerebral Edema)
01/2015 - 01/2012
3COVID-19
10/2022 - 02/2021
2Neoplasms (Cancer)
10/2020 - 02/2012
2Hypoxia (Hypoxemia)
08/2016 - 01/2012
2Infarction (Infarctions)
12/2014 - 01/2012
2Reperfusion Injury
09/2013 - 01/2013
2Parkinson Disease (Parkinson's Disease)
10/2012 - 01/2012
1Severe Acute Respiratory Syndrome
10/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2014
1Alcoholism (Alcohol Abuse)
10/2012
1Substance-Related Disorders (Drug Abuse)
10/2012
1Neuroinflammatory Diseases
09/2012
1Cognitive Dysfunction
09/2012
1Acidosis
07/2012
1Brain Diseases (Brain Disorder)
01/2012
1Alzheimer Disease (Alzheimer's Disease)
01/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012

Drug/Important Bio-Agent (IBA)

7Piroxicam (Feldene)FDA LinkGeneric
08/2022 - 09/2012
5QuercetinIBA
02/2021 - 01/2011
3Malondialdehyde (Propanedial)IBA
01/2015 - 01/2013
3NitritesIBA
01/2015 - 01/2013
3Neuroprotective AgentsIBA
01/2015 - 07/2012
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2013 - 09/2012
2gamma-Aminobutyric Acid (GABA)IBA
08/2022 - 12/2014
2Glutamic Acid (Glutamate)FDA Link
08/2022 - 12/2014
2MelatoninIBA
09/2021 - 04/2014
2Protein Kinase CIBA
09/2021 - 04/2014
2Matrix Metalloproteinases (MMPs)IBA
01/2015 - 07/2012
2Neurotransmitter Agents (Neurotransmitter)IBA
12/2014 - 09/2012
2AntioxidantsIBA
12/2014 - 01/2012
1Glycoproteins (Glycoprotein)IBA
10/2022
1Antiviral Agents (Antivirals)IBA
10/2022
1AngiotensinsIBA
10/2022
1LectinsIBA
10/2022
1Proteins (Proteins, Gene)FDA Link
10/2022
1EnzymesIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1Mitochondrial Proteins (Mitochondrial Protein)IBA
10/2020
1Mitochondrial DNA (mtDNA)IBA
10/2020
1violaceinIBA
10/2020
1Transcription Factors (Transcription Factor)IBA
10/2020
1SilverIBA
10/2020
1Cysteine Proteases (Cysteine Protease)IBA
08/2016
1CalpainIBA
08/2016
1CalciumIBA
08/2016
1Serotonin (5 Hydroxytryptamine)IBA
09/2015
1ResveratrolIBA
01/2015
1Anticonvulsants (Antiepileptic Drugs)IBA
10/2012
1ifenprodilIBA
10/2012
1Tissue Plasminogen Activator (Alteplase)FDA Link
09/2012
1AcidsIBA
09/2012
1Acid Sensing Ion ChannelsIBA
07/2012
1FlavonoidsIBA
07/2012
1oxovanadium IVIBA
02/2012
1Chelating AgentsIBA
02/2012
1GuanineIBA
02/2012
1disalicylaldehyde ethylenediamine (salen)IBA
02/2012

Therapy/Procedure

4Therapeutics
01/2022 - 09/2012
2Drug Therapy (Chemotherapy)
10/2012 - 09/2012
1Combination Drug Therapy (Combination Chemotherapy)
10/2020
1Combined Modality Therapy
10/2020